Effects of vasoactive intestinal polypeptide on neurones of the rat suprachiasmatic nuclei in vitro

Journal of Neuroendocrinology

Volumn 14, Issue 8, 2002, Pages 639-646

  Reed, H E ^a   Cutler, D J ^a   Brown, T M ^a   Brown, J ^a   Coen, C W ^b   Piggins, H D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; BICUCULLINE; G PROTEIN COUPLED RECEPTOR; IONOTROPIC RECEPTOR; MAXADILAN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ADCYAP1 PROTEIN, RAT; CYCLOPEPTIDE; DRUG DERIVATIVE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INSECT PROTEIN; MAXADILAN PROTEIN, INSECT; NEUROPEPTIDE; NEUROPROTECTIVE AGENT; RO 25 1553; RO 25-1553; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL ACTIVATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; EVOKED RESPONSE; HYPOTHALAMUS; IN VITRO STUDY; MALE; NERVE CELL; NERVE CONDUCTION; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECORDING; SUPRACHIASMATIC NUCLEUS; ACTION POTENTIAL; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; PHYSIOLOGY; WISTAR RAT;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ACTION POTENTIALS; ANIMAL; BICUCULLINE; IN VITRO; INSECT PROTEINS; MALE; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; SUPPORT, NON-U.S. GOV'T; SUPRACHIASMATIC NUCLEUS; VASOACTIVE INTESTINAL PEPTIDE; ANIMALS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I;

EID: 0036668074     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2002.00826.x     Document Type: Article

References (44)

1. Neural regulation of circadian rhythms
2. Neurophysiology of the suprachiasmatic circadian pacemaker in mammals
3. The role of glutamate in the photic resetting of the suprachiasmatic nucleus
4. PACAP and glutamate are co-stored in the retinohypothalamic tract
5. Double-labeling of neuropeptide Y-immunoreactive neurons which project from the geniculate to the suprachiasmatic nucleus
6. Intergeniculate leaflet and suprachiasmatic organization and connections in the golden hamster
7. Resetting the biological clock: Mediation of nocturnal circadian shifts by glutamate and NO
8. Gastrin-releasing peptide phase-shifts suprachiasmatic nuclei neuronal rhythms in vitro
9. Vasoactive intestinal polypeptide (VIP) phase-shifts the rat suprachiasmatic nucleus clock in vitro
10. Circadian phase shifts to neuropeptide Y in vitro: Cellular communication and signal transduction
11. Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: A potential daytime regulator of the biological clock
12. Polypeptide with broad biological activity: Isolation from small intestine
13. Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis
14. Distribution of vasoactive intestinal polypeptide in the rat and mouse brain
15. Immunocytochemical localisation of vasoactive intestinal polypeptide-containing cells and processes in the suprachiasmatic nucleus of the rat: Light and electron microscopic analysis
16. Vasoactive intestinal polypeptide (VIP)-like immunoreactive neurons located in the rat suprachiasmatic nucleus receive a direct retinal projection
17. Efferent projections of the suprachiasmatic nucleus II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat
18. Lesions of the suprachiasmatic nucleus indicate the presence of a direct vasoactive intestinal polypeptide-containing projection to gonadotrophin-releasing hormone neurons in the female rat
19. Direct vasoactive intestinal polypeptide-containing projection from the suprachiasmatic nucleus to spinal projecting hypothalamic paraventricular neurons
20. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide
21. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions
22. 2 receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridisation
23. Circadian changes in the expression of vasoactive intestinal peptide 2 receptor mRNA in the rat suprachiasmatic nuclei
24. 1) receptor mRNA in the rat suprachiasmatic and supraoptic nuclei
25. 1 receptor agonists
26. 2 receptor subtype
27. 2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice
28. Vasoactive intestinal polypeptide excitation of central neurons
29. Vasoactive intestinal polypeptide excites mammalian dorsal horn neurons both in vivo and in vitro
30. Vasoactive intestinal polypeptide excites medial pontine reticular formation neurons in the brainstem rapid eye movement sleep-induction zone
31. Evidence for vasoactive intestinal polypeptide (VIP) altering the firing rate of preoptic, septal and midbrain central gray neurons
32. Neuropeptides phase shift the mammalian circadian pacemaker
33. A simple insert for the PDMI-2 microincubator offers mechanical stability for brain slice recording
34. 2 receptor
35. Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist
36. Morphological heterogeneity of the GABAergic network in the suprachiasmatic nucleus, the brain's circadian pacemaker
37. Autoradiographic visualisation of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain
38. Binding sites for pituitary adenylate cyclase-activating polypeptide (PACAP): Comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections
39. Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: An in situ hybridisation study
40. PACAP type I receptor expression in the paraventricular and supraoptic nuclei of rats
41. Facilitatory effects of pituitary adenylate cyclase activating polypeptide (PACAP) on neurons in the magnocellular portion of the rat hypothalamic paraventricular nucleus (PVN) in vitro
42. Patch-clamp analysis of the mechanism of PACAP-induced excitation in rat supraoptic neurons
43. Development of vasoactive intestinal polypeptide mRNA rhythm in the rat suprachiasmatic nucleus
44. 1-R) in the rat brain by in situ RT-PCR